Included In This Lesson
Outline
What is the generic name?
CABOZANTINIB
What is the Trade Name for CABOZANTINIB?
COMETRIQ
What are the Indications for CABOZANTINIB?
- 1 INDICATIONS AND USAGE COMETRIQ is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC). COMETRIQ is a kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC). ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources